Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:aimsTo |
improve patient outcomes
|
| gptkbp:awards |
various industry recognitions
|
| gptkbp:CEO |
gptkb:Dr._John_Doe
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:collaboratesWith |
pharmaceutical companies
|
| gptkbp:develops |
drug delivery systems
|
| gptkbp:focusesOn |
cancer therapeutics
|
| gptkbp:founded |
2019
|
| gptkbp:headquarters |
gptkb:Vancouver,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
DEF Therapeutics
|
| gptkbp:investmentFocus |
private equity firms
|
| gptkbp:partnerships |
various research institutions
|
| gptkbp:researchFocus |
targeted therapies
|
| gptkbp:technology |
therapeutic platforms
|
| gptkbp:tradedOn |
gptkb:TSX_Venture_Exchange
|
| gptkbp:tributaryOf |
multiple drug candidates
|
| gptkbp:website |
www.deftherapeutics.com
|